BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 22142687)

  • 1. Looking beyond borders: integrating best practices in benefit-risk analysis into the field of food and nutrition.
    Tijhuis MJ; Pohjola MV; Gunnlaugsdóttir H; Kalogeras N; Leino O; Luteijn JM; Magnússon SH; Odekerken-Schröder G; Poto M; Tuomisto JT; Ueland O; White BC; Holm F; Verhagen H
    Food Chem Toxicol; 2012 Jan; 50(1):77-93. PubMed ID: 22142687
    [TBL] [Abstract][Full Text] [Related]  

  • 2. State of the art in benefit-risk analysis: introduction.
    Verhagen H; Tijhuis MJ; Gunnlaugsdóttir H; Kalogeras N; Leino O; Luteijn JM; Magnússon SH; Odekerken G; Pohjola MV; Tuomisto JT; Ueland Ø; White BC; Holm F
    Food Chem Toxicol; 2012 Jan; 50(1):2-4. PubMed ID: 21679738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. State of the art in benefit-risk analysis: food and nutrition.
    Tijhuis MJ; de Jong N; Pohjola MV; Gunnlaugsdóttir H; Hendriksen M; Hoekstra J; Holm F; Kalogeras N; Leino O; van Leeuwen FX; Luteijn JM; Magnússon SH; Odekerken G; Rompelberg C; Tuomisto JT; Ueland Ø; White BC; Verhagen H
    Food Chem Toxicol; 2012 Jan; 50(1):5-25. PubMed ID: 21679741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 5. State of the art in benefit-risk analysis: environmental health.
    Pohjola MV; Leino O; Kollanus V; Tuomisto JT; Gunnlaugsdóttir H; Holm F; Kalogeras N; Luteijn JM; Magnússon SH; Odekerken G; Tijhuis MJ; Ueland Ø; White BC; Verhagen H
    Food Chem Toxicol; 2012 Jan; 50(1):40-55. PubMed ID: 21708210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. State of the art in benefit-risk analysis: economics and marketing-finance.
    Kalogeras N; Odekerken-Schröder G; Pennings JM; Gunnlaugsdóttir H; Holm F; Leino O; Luteijn JM; Magnússon SH; Pohjola MV; Tijhuis MJ; Tuomisto JT; Ueland Ø; White BC; Verhagen H
    Food Chem Toxicol; 2012 Jan; 50(1):56-66. PubMed ID: 21871522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. State of the art in benefit-risk analysis: food microbiology.
    Magnússon SH; Gunnlaugsdóttir H; Loveren Hv; Holm F; Kalogeras N; Leino O; Luteijn JM; Odekerken G; Pohjola MV; Tijhuis MJ; Tuomisto JT; Ueland Ø; White BC; Verhagen H
    Food Chem Toxicol; 2012 Jan; 50(1):33-9. PubMed ID: 21679739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRAFO tiered approach for Benefit-Risk Assessment of Foods.
    Hoekstra J; Hart A; Boobis A; Claupein E; Cockburn A; Hunt A; Knudsen I; Richardson D; Schilter B; Schütte K; Torgerson PR; Verhagen H; Watzl B; Chiodini A
    Food Chem Toxicol; 2012 Nov; 50 Suppl 4():S684-98. PubMed ID: 20546818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. European food and nutrition policies in action. Finland's food and nutrition policy: progress, problems and recommendations.
    Milio N
    WHO Reg Publ Eur Ser; 1998; 73():63-75. PubMed ID: 9935290
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to anticipate the assessment of the public health benefit of new medicines?
    Massol J; Puech A; Boissel JP;
    Therapie; 2007; 62(5):427-35. PubMed ID: 18206104
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving food safety in the domestic environment: the need for a transdisciplinary approach.
    Fischer AR; de Jong AE; de Jonge R; Frewer LJ; Nauta MJ
    Risk Anal; 2005 Jun; 25(3):503-17. PubMed ID: 16022686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six Sigma: not for the faint of heart.
    Benedetto AR
    Radiol Manage; 2003; 25(2):40-53. PubMed ID: 12800564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reducing obesity and related chronic disease risk in children and youth: a synthesis of evidence with 'best practice' recommendations.
    Flynn MA; McNeil DA; Maloff B; Mutasingwa D; Wu M; Ford C; Tough SC
    Obes Rev; 2006 Feb; 7 Suppl 1():7-66. PubMed ID: 16371076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Future challenges to microbial food safety.
    Havelaar AH; Brul S; de Jong A; de Jonge R; Zwietering MH; Ter Kuile BH
    Int J Food Microbiol; 2010 May; 139 Suppl 1():S79-94. PubMed ID: 19913933
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perceptions of food risk management among key stakeholders: results from a cross-European study.
    van Kleef E; Frewer LJ; Chryssochoidis GM; Houghton JR; Korzen-Bohr S; Krystallis T; Lassen J; Pfenning U; Rowe G
    Appetite; 2006 Jul; 47(1):46-63. PubMed ID: 16584811
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The paradox of overlapping micronutrient risks and benefits obligates risk/benefit analysis.
    Verkerk RH
    Toxicology; 2010 Nov; 278(1):27-38. PubMed ID: 20188138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Constraints to microbial food safety policy: opinions from stakeholder groups along the farm to fork continuum.
    Sargeant JM; Ramsingh B; Wilkins A; Travis RG; Gavrus D; Snelgrove JW
    Zoonoses Public Health; 2007; 54(5):177-84. PubMed ID: 17542959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.